[1] Heidelberg Pharma - News: HEIDELBERG PHARMA AG starts second clinical phase II study with FOSALVUDINE [Press Release], November 12, 2007. Available at: http://www.heidelberg-pharma.com/news/popup/20071112.html. Accessed 09/08/08. [2] Heidelberg Pharma - News: HEIDELBERG PHARMA AG starts second clinical phase II study with FOSALVUDINE [Press Release], November 12, 2007. Available at: http://www.heidelberg-pharma.com/news/popup/20071112.html. Accessed 09/08/08. [3] Heidelberg - Products - Pipeline: Fosalvudine. Available at: http://www.heidelberg-pharma.com/products/fosalvudine.html. Accessed 09/08/08. [4] Heidelberg Pharma - News: HEIDELBERG PHARMA AG starts second clinical phase II study with FOSALVUDINE [Press Release], November 12, 2007. Available at: http://www.heidelberg-pharma.com/news/popup/20071112.html. Accessed 09/08/08. [5] IAS Conf HIV Pathogen, Treat, Prevent- 4th, 2007 - Abstract WEPEB114LB. [6] Heidelberg Pharma - News: HEIDELBERG PHARMA AG starts second clinical phase II study with FOSALVUDINE [Press Release], November 12, 2007. Available at: http://www.heidelberg-pharma.com/news/popup/20071112.html. Accessed 09/08/08 [7] IAS Conf HIV Pathogen, Treat, Prevent- 4th, 2007 - Abstract WEPEB114LB. [8] IAS Conf - 16th, 2006 - Abstract ThPE0025. [9] IAS Conf - 16th, 2006 - Abstract ThPE0025. [10] Heidelberg - HEIDELBERG PHARMA AG starts second clinical phase II study with FOSALVUDINE [Press Release], November 12, 2007. Available at: http://www.heidelberg-pharma.com/news/popup/20071112.html. Accessed 09/08/08. [11] IAS Conf HIV Pathogen, Treat, Prevent- 4th, 2007 - Abstract WEPEB114LB.
|